Let-7a Targeting TNFAPI3 Promotes Vascular Endothelial Cell Apoptosis of Pediatric Patients with Henoch–Schönlein Purpura via NF-κB Signaling Pathway. (26th February 2022)
- Record Type:
- Journal Article
- Title:
- Let-7a Targeting TNFAPI3 Promotes Vascular Endothelial Cell Apoptosis of Pediatric Patients with Henoch–Schönlein Purpura via NF-κB Signaling Pathway. (26th February 2022)
- Main Title:
- Let-7a Targeting TNFAPI3 Promotes Vascular Endothelial Cell Apoptosis of Pediatric Patients with Henoch–Schönlein Purpura via NF-κB Signaling Pathway
- Authors:
- Cui, Mingming
Liu, Jilong
Geng, Li
Li, Qianqian
Xi, Leiming - Other Names:
- Rajakani Kalidoss Academic Editor.
- Abstract:
- Abstract : Objective . We aimed at exploring the role of let-7a in the pathogenesis of pediatric Henoch–Schönlein purpura (HSP) and its related mechanism. Methods . Fifty-five pediatric HSP patients and 20 paired healthy controls were included. The expressions of let-7a and TNFAIP3 were detected by RT-qPCR or/and western blot. Vessel fibrinoid necrosis was evaluated in skin tissues by PTAH staining. The serum IgA level was measured by ELISA. Cells were transfected with let-7a inhibitor and/or TNFAIP3 siRNA, accompanied by pretreatment with NF- κ B inhibitor PDTC or not. After being cultured in HSP serum, the changes in cell viability, cell apoptosis, apoptosis-related proteins, and NF- κ B pathway-related proteins were detected by CCK8, flow cytometry, and western blot. Results . The let-7a expression level was positively correlated with the serum IgA level and severity degree of vascular fibrinoid necrosis in HSP patients. Let-7a expression was significantly increased, whereas cell viability and TNFAIP3 expression were obviously decreased 48 h after HUVECs were incubated with HSP serum. Let-7a knockdown upregulated the cell viability, whereas it reduced the apoptotic ratio, apoptosis protein expressions (Bax/Bcl2 ratio, cleaved-caspase 3), and NF- κ B pathway activation (reflected by reduced P65 nuclear translocation and p-I κ B α expression) in HUVECs (all p < 0.05 ). The changes induced by let-7a knockdown were obviously reversed by TNFAIP3 siRNA transfection p < 0.05 .Abstract : Objective . We aimed at exploring the role of let-7a in the pathogenesis of pediatric Henoch–Schönlein purpura (HSP) and its related mechanism. Methods . Fifty-five pediatric HSP patients and 20 paired healthy controls were included. The expressions of let-7a and TNFAIP3 were detected by RT-qPCR or/and western blot. Vessel fibrinoid necrosis was evaluated in skin tissues by PTAH staining. The serum IgA level was measured by ELISA. Cells were transfected with let-7a inhibitor and/or TNFAIP3 siRNA, accompanied by pretreatment with NF- κ B inhibitor PDTC or not. After being cultured in HSP serum, the changes in cell viability, cell apoptosis, apoptosis-related proteins, and NF- κ B pathway-related proteins were detected by CCK8, flow cytometry, and western blot. Results . The let-7a expression level was positively correlated with the serum IgA level and severity degree of vascular fibrinoid necrosis in HSP patients. Let-7a expression was significantly increased, whereas cell viability and TNFAIP3 expression were obviously decreased 48 h after HUVECs were incubated with HSP serum. Let-7a knockdown upregulated the cell viability, whereas it reduced the apoptotic ratio, apoptosis protein expressions (Bax/Bcl2 ratio, cleaved-caspase 3), and NF- κ B pathway activation (reflected by reduced P65 nuclear translocation and p-I κ B α expression) in HUVECs (all p < 0.05 ). The changes induced by let-7a knockdown were obviously reversed by TNFAIP3 siRNA transfection p < 0.05 . Besides, PDTC treatment remarkably diminished the anti-apoptosis effect of let-7a knockdown and pro-apoptosis effect of TNFAIP3 siRNA on HUVECs induced by HSP serum. Conclusions . Let-7a knockdown significantly suppressed vascular endothelial cell apoptosis induced by HSP serum by targeting TNFAPI3 via NF- κ B signaling pathway. Our findings provided a potential therapeutic target for the treatment of HSP. … (more)
- Is Part Of:
- Journal of healthcare engineering. Volume 2022(2022)
- Journal:
- Journal of healthcare engineering
- Issue:
- Volume 2022(2022)
- Issue Display:
- Volume 2022, Issue 2022 (2022)
- Year:
- 2022
- Volume:
- 2022
- Issue:
- 2022
- Issue Sort Value:
- 2022-2022-2022-0000
- Page Start:
- Page End:
- Publication Date:
- 2022-02-26
- Subjects:
- Hospital buildings -- Environmental engineering -- Periodicals
Medical technology -- Periodicals
Medical informatics -- Periodicals
610.28 - Journal URLs:
- http://www.hindawi.com/journals/jhe/ ↗
http://multi-science.metapress.com/content/r03085752427/?p=bacc87ee7c194c1aa6a045ab293b1f0f&pi=2 ↗ - DOI:
- 10.1155/2022/3889318 ↗
- Languages:
- English
- ISSNs:
- 2040-2295
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library HMNTS - ELD Digital store
- Ingest File:
- 21137.xml